The company's principal activity is to research, test and develop medications for the control and cure of various diseases and the licensing of its technologies for commercialization by other companies. The company has discovered and is primarily investigating catrix(R), a complex of mucopolysaccharides derived from bovine cartilage. The products sold by the company include its proprietary bovine cartilage material, bio-cartilage(R), as a food supplement, and direct sales to consumers of a line of cosmetic products. Additionally, the company has pursued a program to establish the clinical efficacy of its poly-nag(R) material as an anti-arthritic.
